Table of Content

1 INTRODUCTION 
    1.1 OBJECTIVES OF THE STUDY  
    1.2 MARKET DEFINITION  
           1.2.1 KEY INCLUSIONS & EXCLUSIONS 
    1.3 RESEARCH SCOPE  
           1.3.1 SEGMENTS COVERED 
           1.3.2 GEOGRAPHIC SCOPE 
           1.3.3 YEARS CONSIDERED FOR THE STUDY 
    1.4 CURRENCY USED FOR THE STUDY  
    1.5 MAJOR MARKET STAKEHOLDERS  
    1.6 SUMMARY OF CHANGES  
           1.6.1 RECESSION IMPACT 
2 RESEARCH METHODOLOGY  
    2.1 RESEARCH DATA SOURCES 
           2.1.1 SECONDARY DATA 
           2.1.2 PRIMARY DATA
    2.2 MARKET SIZE ESTIMATION METHODOLOGY  
    2.3 MARKET SHARE ESTIMATION METHODOLOGY  
    2.4 MARKET BREAK DOWN AND DATA TRIANGULATION  
    2.5 RESEARCH ASSUMPTIONS 
    2.6 RESEARCH LIMITATIONS  
           2.6.1 SCOPE RELATED LIMITATIONS 
           2.6.2 METHODOLOGY RELATED LIMITATIONS
    2.7 RISK ASSESSMENT  
    2.8 RECESSION IMPACT ASSESSMENT APPROACH  
3 EXECUTIVE SUMMARY  
4 PREMIUM INSIGHTS  
5 MARKET OVERVIEW  
    5.1 MARKET DYNAMICS  
           5.1.1 MAJOR DRIVERS 
           5.1.2 KEY RESTRAINTS
           5.1.3 KEY GROWTH OPPORTUNITIES 
           5.1.4 INDUSTRY-SPECIFIC CHALLENGES 
    5.2 TARIFF AND REGULATORY LANDSCAPE 
           5.2.1 TARIFF RELATED TO MINIMALLY INVASIVE MEDICAL ROBOTICS, IMAGING VISUALISATION SYSTEMS & SURGICAL INSTRUMENTS
           5.2.2 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
           5.2.3 REGULATORY TRENDS, BY REGION
    5.3 VALUE CHAIN ANALYSIS 
    5.4 SUPPLY CHAIN ANALYSIS 
    5.5 ECOSYSTEM ANALYSIS 
    5.6 TECHNOLOGY ANALYSIS 
           5.6.1 KEY TECHNOLOGIES
                    5.6.1.1  LAPAROSCOPY
                    5.6.1.2  ABLATION 
                    5.6.1.3  ELECTROSURGERY
                    5.6.1.2  POWERED SURGICAL PRODUCT 
           5.6.2 COMPLEMENTARY TECHNOLOGIES
                    5.6.2.1  ROBOTIC SURGERY
                    5.6.2.2  DIGITAL SOLUTION (AI, IOT)
                    5.6.2.3  MEDICAL/ SURGICAL IMAGING
           5.6.3 ADJECENT TECHNOLOGIES
                    5.6.3.1  ENDOSCOPE
                    5.6.3.2  SURGICAL IMPLANTS
    5.7 REIMBURSEMENT SCENARIO 
    5.8 INVESTMENT AND FUNDING SCENARIO 
    5.9 TRADE DATA 
    5.10 PATENT DATA  
    5.11 PORTER’S FIVE FORCE ANALYSIS 
    5.12 PRICING ANALYSIS 
           5.12.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
           5.12.2 AVERAGE SELLING PRICE TREND, BY REGION
    5.13 CASE STUDY ANALYSIS 
    5.14 KEY CONFERENCES AND EVENTS IN 2024-25 
    5.15 KEY STAKEHOLDERS & BUYING CRITERIA 
           5.15.1 KEY STAKEHOLDERS IN THE BUYING PROCESS
           5.15.2 BUYING CRITERIA
    5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 
    5.17 CUSTOMER UNMET NEEDS IN MINIMALLY INVASIVE MEDICAL ROBOTICS, IMAGING VISUALISATION SYSTEMS & SURGICAL INSTRUMENTS MARKET 
6 MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT (USD MILLION; 2021—2029) *  
    6.1 SURGICAL DEVICES 
           6.1.1 HANDHELD INSTRUMENTS
                    6.1.1.1 Tubular Retractor
                    6.1.1.2 Dilator
                    6.1.1.3 Suturing Instruments
                    6.1.1.4 Probes
                    6.1.1.5 Laser fiber devices
           6.1.2 GUIDING DEVICES
                    6.1.2.1 Guiding catheters
                    6.1.2.2 Guidewires
           6.1.3 INFLATION SYSTEMS
                    6.1.3.1 Balloon Catheters
                    6.1.3.2 Balloon inflation system
           6.1.4 LAPAROSCOPY DEVICES
                    6.1.4.1 Laparoscope
                    6.1.4.2 Trocar and Cannula
                    6.1.4.3 RASP (Robotic- Assisted Simple Prostatectomy)
                    6.1.4.4 Graspers and Dissectors
    6.2 IMAGING & VISUALIZATION SYSTEMS 
           6.2.1 ULTRASOUND
           6.2.2 CT IMAGING
           6.2.3 MRI IMAGING
           6.2.4 X-RAY IMAGING
           6.2.5 VISUALIZATION SYSTEMS
    6.3 ELECTROSURGICAL DEVICES 
           6.3.1 ELECTROSURGICAL GENERATORS & ACCESSORIES
           6.3.2 ELECTROCAUTERY DEVICES
    6.4 ENDOSCOPY DEVICES 
           6.4.1 RIGID ENDOSCOPES
           6.4.2 FLEXIBLE ENDOSCOPES
           6.4.3 DIAGNOSTIC ENDOSCOPES
    6.5 MEDICAL ROBOTICS 
           6.5.1 ROBOTIC SYSTEMS
           6.5.2 ROBOTIC INSTRUMENTS
           6.5.4 ROBOTIC SOFTWARES & SERVICES
7 MINIMALLY INVASIVE SUREGRY MARKET, BY APPLICATION (USD MILLION; 2021—2029) * 
    7.1 CARDIO-THORACIC SURGERY 
    7.2 VASCULAR SURGERY 
    7.3 NEUROLOGICAL SURGERY 
    7.4 ENT & RESPIRATORY SURGERY 
    7.5 COSMETIC SURGERY 
    7.6 GASTROINTESTINAL & ABDOMINAL SURGERY 
    7.7 GYNECOLOGICAL SURGERY 
    7.8 UROLOGICAL SURGERY 
    7.9 ORTHOPEDIC SURGERY 
    7.10 ONCOLOGY SURGERY 
    7.11 DENTAL SURGERY 
    7.12 OTHERS 
8 MINIMALLY INVASIVE SURGERY MARKET, BY END USER (USD MILLION; 2021—2029) *  
    8.1 HOSPITALS, CLINICS & ABLATION CENTERS 
    8.2 AMBULATORY SURGICAL CENTERS 
    8.3 ORTHOPEDIC, EMERGENCY & TRAUMA CENTERS 
    8.3 OTHERS 
9 MINIMALLY INVASIVE SURGERY MARKET, BY REGION (USD MILLION; 2021—2029)* 
    9.1 NORTH AMERICA 
           9.1.1 RECESSION IMPACT
           9.1.2 US
           9.1.3 CANADA 
    9.2 EUROPE  
           9.2.1 RECESSION IMPACT
           9.2.2 GERMANY
           9.2.3 UK
           9.2.4 FRANCE
           9.2.5 ITALY 
           9.2.6 SPAIN 
           9.2.7 REST OF EUROPE
    9.3 ASIA-PACIFIC 
           9.3.1 RECESSION IMPACT
           9.3.2 JAPAN 
           9.3.3 CHINA 
           9.3.4 INDIA 
           9.3.5 SOUTH KOREA 
           9.3.6 AUSTRALIA 
           9.3.7 REST OF ASIA-PACIFIC
    9.4 LATIN AMERICA 
           9.4.1 RECESSION IMPACT
           9.4.2 BRAZIL
           9.4.3 MEXICO
           9.4.4 REST OF LATIN AMERICA 
    9.5 MIDDLE EAST AND AFRICA  
           9.5.1 RECESSION IMPACT
           9.4.3 GCC COUNTRIES
10 COMPETITIVE LANDSCAPE  
     10.1 OVERVIEW  
     10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 
     10.3 REVENUE ANALYSIS OF KEY PLAYERS (2023)  
     10.4 MARKET SHARE ANALYSIS FOR TOP 5 GLOBAL PLAYERS (IN TERMS OF %REVENUE, IN 2022)  
             10.4.1 MINIMALLY INVASIVE MEDICAL ROBOTICS 
             10.4.2 IMAGING VISUALISATION SYSTEMS
             10.4.3 SURGICAL INSTRUMENTS
             10.4.4 ELECTROSURGICAL DEVICES
             10.4.5 ENDOSCOPY DEVICES
     10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 
             10.5.1 STARS 
             10.5.2 EMERGING LEADERS
             10.5.3 PERVASIVE PLAYERS
             10.5.4 PARTICIPANTS
             10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
                        10.5.5.1 COMPANY FOOTPRINT
                        10.5.5.2 REGION FOOTPRINT 
                        10.5.5.3 PRODUCT FOOTPRINT
                        10.5.5.4 APPLICATION FOOTPRINT 
                        10.5.5.5 END-USER FOOTPRINT
     10.6 COMPANY EVALUATION MATRIX: STARTUPS/ SMES, 2023 
             10.6.1 PROGRESSIVE COMPANIES
             10.6.2 RESPONSIVE COMPANIES
             10.6.3 DYNAMIC COMPANIES
             10.6.4 STARTING BLOCKS
             10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
                        10.6.5.1 DETAILED LIST OF KEY STARTUPS/SMES
                        10.6.5.2 COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 
     10.7 COMPETITIVE SCENARIO AND TRENDS (2021-2023)  
             10.7.1 PRODUCT LAUNCHES
             10.7.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
             10.7.3 MERGERS & ACQUISITIONS
             10.7.4 EXPANSIONS
     10.8 PRODUCT COMPARISON  
     10.9 COMPANY VALUATION AND FINANCIAL METRICS  
11 COMPANY PROFILES** 
(Business Overview, Products Offered, Industry-specific Developments for 2021-2023)***
     11.1 KEY COMPANIES  
             11.1.1 MEDTRONIC, PLC
             11.1.2 JOHNSONS & JOHNSONS
             11.1.3 ABBOTT LABORATORIES
             11.1.4 STRYKER CORPORATION
             11.1.5 BECTON, DICKINSON AND COMPANY
             11.1.6 SIEMENS HEALTHINEERS
             11.1.7 SMITH & NEPHEW
             11.1.8 PHILIPS HEALTHCARE
             11.1.9 FUJIFILM CORPORATION
             11.1.10 COOPERSURGICAL INC.
             11.1.11 GE HEALTHCARE
             11.1.12 BOSTON SCIENTIFIC
             11.1.13 ABBOTT LABORATORIES
             11.1.14 TELEFLEX
             11.1.15 B. BRAUN MELSUNGEN
     11.2 OTHER PLAYERS  
             11.2.1 COOK MEDICAL
             11.2.2 ZIMMER BIOMET HOLDINGS
             11.2.3 OLYMPUS CORPORATION
             11.2.4 INTUITIVE SURGICAL INC.
             11.2.5 KARL STORZ
             11.2.6 EDWARDS LIFESCIENCES CORP
             11.2.7 NIPRO CORPORATION
             11.2.8 GETINGE AB
             11.2.9 INTEGRA LIFESCIENCES
             11.2.10 NUVASIVE INC.
             11.2.11 CONMED CORPORATION 
             11.2.12 APPLIED MEDICAL
             11.2.13 ACCURAY
             11.2.14 RICHARD WOLF
             11.2.15 ATEC SPINE, INC.
12 APPENDIX